YourChoice Therapeutics, a biotech company developing new contraceptives for men has raised $15M in Series A funding led by Future Ventures with participation from North South Ventures, RH Capital and Olive Tree Capital. According to reporting the company will use the new funds to conduct its first human trials.
YourChoice Therapeutics got started in 2018, initially with the goal to develop a non-hormonal birth control alternative for women, but eventually realized that their drug could also be taken by men. So far the company has shown its molecule works as a contraceptive in mice and non-human primates. The company’s goal is to dose the first human in the first half of 2023.
